Learning Objectives: After reading this article and watching the accompanying videos, the participant should be able to: 1. Assess patients seeking facial volumization and correlate volume deficiencies anatomically. 2.
View Article and Find Full Text PDFBackground: U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc.
View Article and Find Full Text PDFBackground: There are numerous methods of assessing patient satisfaction with botulinum toxin type A neuromodulation of the glabellar rhytids. As the use of aesthetic neuromodulation increases both in breadth and number of procedures, there is a need for more comprehensive tools to evaluate patient-reported outcomes. The FACE-Q is a recently validated patient-reported outcome instrument that can be used to measure patient perceptions of botulinum toxin type A neuromodulation.
View Article and Find Full Text PDFBackground: The Plastic Surgery In-Service Training Exam (PSITE) is a multiple-choice examination taken by plastic surgery trainees to provide an assessment of plastic surgery knowledge.
Objective: The purpose of this study was to evaluate cosmetic questions and determine overlap with national procedural data.
Methods: Digital syllabi of six consecutive PSITE administrations (2008-2013) were analyzed for cosmetic surgery topics.
Background: The demand for minimally invasive cosmetic procedures has continued to rise, yet few studies have examined this patient population.
Objectives: This study sought to define the demographics, social characteristics, and motivations of patients seeking minimally invasive facial cosmetic procedures.
Methods: A prospective, single-institution cohort study of 72 patients was conducted from 2011 through 2014 at an urban academic medical center.